If you recall, I reported a few months ago that there was a pending class-action suit against the manufacturers of Gadolinium-based contrast agents used in the MRI scan process.
Post: 03/15/2009
http://ijulian.blogspot.com/2009/03/mripending-class-action-lawsuit.html
According to my sources, Bayer AG (one of the product makers of the dangerous agent that is ingested to facilitate a proper reading of an MRI or MRA) has confirmed that they have reached agreements in principle with several of the plaintiffs in the U.S. to settle without admission of liability.
In their causes of action for the class-action suit, the plaintiffs alleged that individuals who ingested the contrast agent under the supervision of hospital staff developed the rare deadly disease NSF otherwise known as Nephrogenic systemic Fibrosis as a direct result of exposure.
Currently, there is no treatment or cure for NSF.
And, Bayer AG appears to be jumping the gun a bit.
Individuals who are suffering from nephrogenic systemic fibrosis due to the contrast agent in question - that I have been in touch with - have informed me that they were not aware that any settlement talks were even entered into yet!
News at 11!
No comments:
Post a Comment